The most rigorous science fails to move people when the language around it is built for the wrong room.

What we do

We work across the strategy, language, and execution of science communication, from foundational story architecture to fit-for-purpose messaging to publication-ready content.

Our work ranges from deeply technical to broadly accessible, but the approach holds: understand the audience, clarify the decision they need to make, and build the language that guides them there. Knowledge translation is core to this. It is the deliberate work of moving scientific evidence to the people who can act on it, investors, regulators, clinicians, funders, communities. It is the difference between a finding that sits in a journal and one that changes a funding decision, a clinical protocol, or a public health response.

The foundation that defines how your organization, platform, or program speaks across audiences and channels. Core narrative, value proposition, audience-specific messaging, and key claims mapped to evidence, built to serve fundraising, regulatory, program, and public audiences at once.

The written narrative behind a raise or a deal: pitch narrative, one-pagers, executive summaries, and the value proposition that makes complex science legible to a non-specialist while attention is finite and the story is priced in real time.

A dedicated practice, led by communicators with deep roots in global health, journalism, and policy. Making complex, high-stakes work approachable to the public, to partners, and to people inside the institution, because bold ambitions need stories that move people, not just inform them.

Structured writing for regulatory submissions, clinical trial communications, and patient-facing materials. Precise, compliant, and calibrated to the audience and the regulatory environment, grounded in FDA AdPromo training, and practiced across pharma and the One Health and public-health arenas.

An editorial plan for organizations building a sustained presence in the scientific or public conversation, and the content and executive positioning that make scientific leaders credible, substantive voices in their field.

Who this is for

Communications strategy earns its place wherever the language is load-bearing.

A fundraise, when the narrative is the asset.

A regulatory decision, where precision is non-negotiable.

A public health crisis, when trust and speed are needed together.

An education opportunity, where belief, not information, is the goal.

A clinical readout, when the framing has to be ready before the number lands.

What is knowledge translation?

The deliberate work of moving scientific evidence to the people who can act on it: investors, regulators, clinicians, funders, and communities. It is the difference between a finding that sits in a journal and one that reaches a decision.

Do you write for regulated environments?

Yes. Regulatory submissions, clinical trial communications, and patient-facing materials, grounded in FDA AdPromo training and practiced across pharma, global health, and public health.

Do you place media, or only write?

Both, with a bias toward substance: narrative and messaging first, then the media relations, bylines, and executive visibility that carry it. We will not pitch a story the science cannot support.

Who leads the global health work?

A dedicated global health and development communications practice, staffed by communicators with roots in global health, journalism, and policy, rather than a generalist team taking on a global health brief.